Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/16/2026

1. NVDA
2. CRM
3. SPY
4. USO
5. META
6. MU
7. PLAY
8. QQQ
9. SYY
10. JPM

Go back to Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy
ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 92.77 --0 (-0%)
Previous Close $92.77    52 Week High $35.04 
Open $92.77    52 Week Low $26.97 
Day High $92.77    P/E N/A 
Day Low $92.77    EPS $0.00 
Volume 10,293       

ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 92.77 --0 (-0%)
Previous Close $92.77    52 Week High $35.04 
Open $92.77    52 Week Low $26.97 
Day High $92.77    P/E N/A 
Day Low $92.77    EPS $0.00 
Volume 10,293       

Daiichi Sankyo Co Limited Sponsored ADR (AMEX: DSNKY) Delayed: 18.29 --0 (-0%)
Previous Close $18.29    52 Week High $26.24 
Open $18.29    52 Week Low $18.86 
Day High $18.29    P/E N/A 
Day Low $18.29    EPS $0.00 
Volume 62